FDA approves Incyte’s retifanlimab combo for SCAC treatment
The US FDA has approved Incyte’s Zynyz (retifanlimab-dlwr) in conjunction with carboplatin and paclitaxel (platinum-based chemo).
The US FDA has approved Incyte’s Zynyz (retifanlimab-dlwr) in conjunction with carboplatin and paclitaxel (platinum-based chemo).
What's Your Reaction?
